MedTrace Logo

A Community-based Depression Screening Intervention for Middle-aged Suicide

NCT02468466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89700

Last updated 2015-06-10

No results posted yet for this study

Summary

The purpose of this study is to examine the effectiveness of a community-based depression-screening program for suicide prevention among middle-aged adults, the investigators conducted a quasi-experimental intervention study, using a parallel cluster design with communities at municipal level as the unit of allocation and individuals as the unit of analysis.

Conditions

  • Suicide

Interventions

BEHAVIORAL

Multi-level suicide prevention programs

The intervention included both screening and educational components. The screening component invited residents aged 36-64 years to participate in a two-step screening program. In the initial screening, a self-report questionnaire were mailed to all of those residents in the priority districts with a past high suicide rate. The second stage was conducted for the participants who screened positive though a semi-structural interview. Based on the results, participants who were diagnosed with a major depressive episode were provided with a referral to a psychiatry and support for treatment adherence. Written feedback on the screening results was mailed to all respondents. The educational component was implemented through workshops open to the general public (3 times every year) and local public newsletters (twice every year) designed to improve access and adherence to treatment and to reduce stigma associated with suicide and depression.

BEHAVIORAL

Suicide prevention program as usual

Usual mental health program (not including depression screening among middle-aged)

Sponsors & Collaborators

  • Aomori University of Health and Welfare

    lead OTHER

Principal Investigators

  • Hirofumi Oyama, MD, PhD · Aomori University of Health and Welfare

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
36 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02468466 on ClinicalTrials.gov